Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05177133
Title Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) (AuspiCiOus)
Acronym AuspiCiOus
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD

Facility Status City State Zip Country Details
Academic Medical Center, Medical Oncology RECRUITING Amsterdam 1100 DD Netherlands Details
Amsterdam UMC, location VUmc RECRUITING Amsterdam Netherlands Details
Catharina ziekenhuis RECRUITING Eindhoven Netherlands Details
Medisch Centrum Leeuwarden NOT_YET_RECRUITING Leeuwarden Netherlands Details
LUMC NOT_YET_RECRUITING Leiden Netherlands Details
Radboud UMC RECRUITING Nijmegen Netherlands Details
Erasmus MC NOT_YET_RECRUITING Rotterdam Netherlands Details
UMC Utrecht RECRUITING Utrecht Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field